The Lancet Regional Health. Europe (May 2024)

Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?

  • Helena Jernström,
  • Lisa Rydén

DOI
https://doi.org/10.1016/j.lanepe.2024.100896
Journal volume & issue
Vol. 40
p. 100896

Abstract

Read online

No abstracts available.